Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion
Karin G. F. Gerritsen, Roel Goldschmeding(University Medical Center Utrecht), Jack F.M. Wetzels(Radboud University Nijmegen), Leon Xu(FibroGen (United States)), Erik Christensen(Institute of Genetics), Jaap A. Joles(University Medical Center Utrecht), Maarten P. Koeners(University Medical Center Utrecht), Tri Q. Nguyen(Utrecht University), Dongxia Li(Dalian University), Hilde P.E. Peters(Radboud University Nijmegen), Robbert J. Kok(Utrecht University), Noëlynn Oliver(FibroGen (United States)), P Verroust(Institut de la Vision)
Cited by 27
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396